GEN Exclusives

More »

GEN Poll

More »
Jun 06, 2014

DTC Testing Regulation

In a recent survey, the Science Advisory Board asked 500 of its U.S. members to share their views on the direct-to-consumer (DTC) testing industry, specifically in the context of the FDA's warning letter to 23andMe back in November of 2013. (You can see the results of that survey here.) What are your thoughts on the issue?

Should the FDA further extend regulations regarding DTC testing technologies?

Yes, there is a significant lack of regulation in this area
Yes, but only for a subset of these products
No, it would have a negative effect on these innovations
No, consumers should have access to as much personalized medical info as possible

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »